Erasca, Inc. Common Stock ERAS
$16.03
+3.69%
at last close
Analyst Consensus
- Consensus Rating
- Buy (7 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $22.56
- Implied Upside
- +40.7%
- Price Target Range
- $18.00 – $30.00
- Analysts (12 mo)
- 9
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-14 | B of A SecuritiesAlec Stranahan |
Maintains | Neutral | $18 → $20 |
| 2026-08-13 | GuggenheimPaul Jeng |
Maintains | Buy | $20 → $21 |
| 2026-08-12 | HC Wainwright & Co.Andres Y. Maldonado |
Maintains | Buy | $18 → $22 |
| 2026-07-20 | Morgan StanleySean Laaman |
Maintains | Equal-weight | $12 → $21 |
| 2026-07-14 | B of A SecuritiesAlec Stranahan |
Maintains | Neutral | $16 → $18 |
| 2026-06-04 | B of A SecuritiesAlec Stranahan |
Upgrades | Underperform → Neutral | $9 → $16 |
| 2026-05-12 | MizuhoJoseph Catanzaro |
Maintains | Outperform | $28 → $26 |
| 2026-04-27 | StifelLaura Prendergast |
Maintains | Buy | $20 → $30 |
| 2026-03-18 | JP MorganAnupam Rama |
Maintains | Overweight | $24 → $25 |
| 2026-03-16 | GuggenheimMichael Schmidt |
Maintains | Buy | $12 → $20 |
| 2026-03-13 | Piper SandlerKelsey Goodwin |
Maintains | Overweight | $11 → $18 |
| 2026-03-13 | MizuhoJoseph Catanzaro |
Maintains | Outperform | $16 → $19 |
| 2026-03-13 | HC Wainwright & Co.Andres Y. Maldonado |
Maintains | Buy | $15 → $20 |
| 2026-03-06 | Clear StreetKaveri Pohlman |
Maintains | Buy | $11 → $20 |
| 2026-01-26 | HC Wainwright & Co.Andres Y. Maldonado |
Maintains | Buy | $11 → $15 |
| 2026-01-16 | Piper SandlerKelsey Goodwin |
Maintains | Overweight | $5 → $11 |
| 2026-01-13 | HC Wainwright & Co.Andres Y. Maldonado |
Maintains | Buy | $6 → $11 |
| 2026-01-07 | Piper SandlerKelsey Goodwin |
Initiates coverage on | Overweight | $5 |
| 2025-12-09 | MizuhoGraig Suvannavejh |
Maintains | Outperform | $4 → $5 |
| 2025-11-14 | GuggenheimMichael Schmitz |
Maintains | Buy | $3 → $5 |
| 2025-10-16 | StifelLaura Prendergast |
Initiates coverage on | Buy | $4 |
| 2025-09-03 | B of A SecuritiesAlec Stranahan |
Downgrades | Buy → Underperform | $4 → $1 |
| 2025-08-18 | Morgan StanleyJeffrey Hung |
Downgrades | Overweight → Equal-weight | $4 → $2 |
| 2025-04-30 | HC Wainwright & Co.Andres Maldonado |
Reiterates | Buy | $6 |
| 2025-03-26 | Raymond JamesLaura Prendergast |
Initiates coverage on | Outperform | $5 |
| 2025-03-21 | Goldman SachsChris Shibutani |
Maintains | Buy | $4 → $3 |
| 2025-03-21 | HC Wainwright & Co.Andres Maldonado |
Reiterates | Buy | $6 |
| 2025-03-07 | Morgan StanleyJeffrey Hung |
Assumes | Overweight | $4 |
| 2025-01-07 | B of A SecuritiesAlec Stranahan |
Upgrades | Neutral → Buy | $5 |
| 2024-11-18 | JefferiesMaury Raycroft |
Initiates coverage on | Buy | $6 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $16.03
- Market Cap
- $5.41 billion
- 52-Week Range
- $1.47 – $24.28
- Average Volume
- 5.04 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.